Our results have demonstrated for the first time that the mechanism of matrine suppressing the cell growth of DLBCL is the inhibition of CaMKIIγ/c-Myc/CDK6 signaling pathway. The gene discussed is CDK6; the disease is diffuse large B-cell lymphoma.